Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events

BACKGROUND: Immune checkpoint inhibiting antibodies were introduced into routine clinical practice for cancer patients. Checkpoint blockade has led to durable remissions in some patients, but may also induce immune-related adverse events (irAEs). Lung cancer patients show an increased risk for compl...

Descripción completa

Detalles Bibliográficos
Autores principales: Läubli, Heinz, Balmelli, Catharina, Kaufmann, Lukas, Stanczak, Michal, Syedbasha, Mohammedyaseen, Vogt, Dominik, Hertig, Astrid, Müller, Beat, Gautschi, Oliver, Stenner, Frank, Zippelius, Alfred, Egli, Adrian, Rothschild, Sacha I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964701/
https://www.ncbi.nlm.nih.gov/pubmed/29789020
http://dx.doi.org/10.1186/s40425-018-0353-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964701/
https://www.ncbi.nlm.nih.gov/pubmed/29789020
http://dx.doi.org/10.1186/s40425-018-0353-7

Ejemplares similares